Poul Sørensen

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

A-apoteket FMBA is a chain of pharmacies with over 90 locations and more than 200 pharmacy branches and sales throughout Denmark. A-apoteket is based in Hørsholm, DK, and their employees include a manager, sales director, CFO, chain consultants, assortment coordinators, campaign advertising manager, art director, education and event coordinator, and e-commerce and digital marketing manager. The Danish company offers both physical stores and online shopping at apoteket-online.dk, where customers can shop directly with their local pharmacy. The private company's board consists of eight pharmacists, and their chain office can be contacted at info @ a-apoteket.dk or phone 7020 7825.

QAtor A/S develops automated and web-based electronic compliance management solutions for quality assurance management. It develops tool that automates business processes and integrate them with applications. The firm assists life science companies with comprehensive documentation and compliance management solutions for governmental agencies. The company was founded by Tim Kehling Pedersen on July 1, 2005 and is headquartered in Bagsværd, Denmark.

Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium.

MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark.

Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden.

Brabantse Ontwikkelings Maatschappij Holding BV (BOM) is an industrial and economic development agency headquarterd in Tilburg in the southern Netherlands. Established in 1983, BOM is funded and financed by the Dutch State and the Province of Noord-Brabant. The firm offers a range of services designed to create, develop, maintain and improve the industrial structure of the region through four core activities: venture capital, foreign investment, new business and industrial parks. In particular BOM manages the Technostartersfonds, also known as the TechnoStars funds, which are regional venture capital investment vehicles based in Eindhoven. The investors are primarily institutions and high-net worth private individuals.